The role of calcium-independent phospholipase A 2 (iPLA 2 )-produced arachidonic acid (AA) in acetylcholine (ACh)-mediated, endothelium-dependent vascular relaxation was investigated. ACh-induced relaxation of phenylephrine-constricted isolated rat mesenteric resistance arteries was attenuated following pretreatment with (E)-6-(bromomethylene)tetrahydro-3-(1-naphthalenyl)-2H-pyran-2-one (BEL; 1 M; p Ͻ 0.01), a highly selective suicide substrate inhibitor of iPLA 2 . Following BEL, the ACh relaxation could be completely restored following pretreatment with picomolar quantities of the cell-permeant methyl ester analog of AA (arachidonic acid methyl ester, AAMe). Higher amounts of AA-Me (1 M) had a direct endothelium-dependent relaxing action, which was inhibited by the nitric-oxide synthase inhibitor (N -nitro-L-arginine; 100 M), independent of ACh, and unaffected by BEL. Neither the ACh relaxation restoring action nor the direct relaxing action of AA-Me was affected by preincubation with inhibitors of the lipoxygenase (esculetin, 10 M) or cytochrome P450 monooxygenase (17-octadecynoic acid; 10 M) pathways; and both actions of AA-Me were enhanced following preincubation with the cyclooxygenase inhibitor indomethacin (10 M; p Ͻ 0.05). The results of the present study indicate that iPLA 2 -produced AA plays an essential role in ACh-mediated endothelium-dependent relaxation in rat mesenteric resistance arteries.
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Vascular endothelium modulates blood pressure and flow by producing and releasing factors, which regulate the tone of the underlying smooth muscle. The pivotal role of endothelium-derived relaxing factor, now known to be nitric oxide (NO) generated from the metabolism of L-arginine, is well established (Palmer et al., 1987) . In addition, other factors including AA and its metabolites may also contribute significantly to endothelium-mediated relaxation (for reviews, see Quilley et al., 1997; Campbell and Harder, 1999; Feletou and Vanhoutte, 1999; Quilley and McGiff, 2000) . However, the molecular identity of the phospholipase(s) responsible for AA release in endothelial cells involved in the endothelium-dependent relaxation of smooth muscle has not been established.
AA can be released in vascular tissue via multiple pathways. By analogy to the other cell types that have been more extensively investigated, the majority of agonist-induced AA release in endothelial cells is likely mediated by intracellular phospholipase A 2 (PLA 2 ). Within the PLA 2 superfamily of enzymes, there are two distinct families of intracellular PLA 2 . Both a Ca 2ϩ -dependent PLA 2 (cPLA 2 ) and a Ca 2ϩ -independent PLA 2 (iPLA 2 ) are present in mammalian cells Gross, 1985, 1996; Gross et al., 1993 ; for review, see Gijon and Leslie, 1997) . In circulating cells (e.g., platelets, macrophages), the majority of intracellular PLA 2 activity appears to be mediated by cPLA 2 , whereas iPLA 2 appears to be the predominant activity present in other cell types (Wolf and Gross, 1985; Miyake and Gross, 1992; Wolf et al., 1995) . Recent studies indicate that both cPLA 2 and iPLA 2 can participate in agonist-induced AA release (Lehman et al., 1993; Akiba et al., 1999; Murakami et al., 1999) . McHowat et al. (2001) recently described an iPLA 2 activity in endothelial cells that was selective for plasmalogen substrate and inhibited by (E)-6-(bromomethylene)tetrahydro-3-(1-naphthalenyl)-2H-pyran-2-one (BEL).
In the present study, we investigated the role of iPLA 2 , iPLA 2 -derived AA, and AA metabolites in acetylcholine (ACh)-induced, endothelium-dependent relaxation of rat mesenteric resistance arteries. To determine the types of ABBREVIATIONS: NO, nitric oxide; NOS, nitric-oxide synthase; eNOS, endothelial NOS; PLA 2 , phospholipase A 2 ; cPLA 2 , Ca 2ϩ -dependent PLA 2 ; iPLA 2 , Ca 2ϩ -independent PLA 2 ; AA, arachidonic acid; AA-Me, AA methyl ester; PE, phenylephrine; BEL, (E)-6-(bromomethylene)tetrahydro-3-(1-naphthalenyl)-2H-pyran-2-one; 17-ODYA, 17-octadecynoic acid; AACOCF 3 , arachidonyl trifluoromethyl ketone; L-NNA, N -nitro-L-arginine; ACh, acetylcholine; [Ca 2ϩ ] i , intracellular calcium concentration.
intracellular phospholipases involved in ACh-mediated AA release in endothelial cells, BEL, a selective mechanismbased inhibitor, which possesses a 1000-fold selectivity for the iPLA 2 versus the cPLA 2 families of enzymes (Hazen et al., 1991) , was utilized. The role of AA itself or AA metabolites was assessed utilizing inhibitors of the cyclooxygenase (indomethacin), lipoxygenase (esculetin), or cytochrome P450 monooxygenase (17-octadecynoic acid, 17-ODYA) pathways. We now report that BEL inhibits ACh-mediated vascular relaxation, which can be restored by provision of a cell-permeant AA derivative, and that iPLA 2 -derived AA itself, and not an eicosanoid metabolite, is essential for ACh-mediated relaxation in these vessels.
Materials and Methods
Vessel Preparation.Vessel isolation and cannulation methods were similar to those previously described (Boyle and Maher, 1995) . Mesenteric tissue was removed from halothane-anesthetized Sprague-Dawley rats (250 -350g) and the fourth branch of the mesenteric artery (200-to 250-m outer diameter) was dissected at 4°C in a HEPES buffer consisting of 135 mM NaCl, 2.6 mM NaHCO 3 , 0.34 mM Na 2 HPO 4 , 0.44 mM KH 2 PO 4 , 5 mM KCl, 1.4 mM CaCl 2 , 1.17 mM MgSO 4 , 0.025 mM EDTA, 10 mM HEPES, and 5.5 mM glucose (pH 7.35-7.40 ). Arteries were cannulated with two glass cannulae, mounted in a bath filled with HEPES buffer, and pressurized to 40 mm Hg transmural pressure; temperature was maintained at 34 Ϯ 0.5°C. After an equilibration period of 60 min, the integrity of vascular smooth muscle and endothelial function was assessed by contracting the vessel with phenylephrine (PE; 1-10 M), and then adding ACh (1 M). Vessels with a strong uniform response to PE and in which ACh reversed the 10 M PE-induced constriction by more than 90% for 5 min were studied. Vessels that did not respond in this manner were considered damaged and were not studied further. A camera attached to the video port on the microscope was used to visualize the artery, and a computer-based image analysis system was used to continuously monitor and record the inner and the outer vessel diameters. All solutions and drugs were added to the bath.
Effects of PLA 2 Inhibitors. In these experiments, we studied the effect of the iPLA 2 inhibitor, BEL, on 1 M ACh relaxation of 10 M PE-constricted arteries. After the initial PE and ACh application, BEL was added to the bath (10 min) followed by washout and reapplication of PE and ACh. The dose response to BEL was determined by repeating this sequence using increasing concentrations of BEL. A similar approach was used to test the effect of the nonspecific PLA 2 inhibitor, arachidonyl trifluoromethyl ketone (AACOCF 3 ). Assuming that ACh may activate iPLA 2 and thereby increase the effectiveness of the pretreatment with the suicide substrate BEL, additional experiments were conducted in which ACh (1 M) was included with BEL during the 10-min pretreatment period. Preliminary time-control experiments in the absence of the inhibitors demonstrated that the ACh (1 M) relaxation remained constant over 4 h of repeated ACh applications.
AA Effects on ACh Relaxation after BEL. These experiments were conducted to determine whether application of the cell-permeant analog of the iPLA 2 product AA, AA-methyl ester (AA-Me), could restore the ACh-induced relaxation attenuated by BEL pretreatment. Since fatty acids are transported across cell membranes with concomitant thioesterification to facilitate their utilization in subsequent oxidation or lipid metabolic processes, we explored the effects of AA-Me, which we envisaged would have access to intracellular membrane compartments (without thioesterification) where it would be de-esterified to AA by intracellular esterases. After demonstrating that ACh relaxation was blocked by BEL, the vessel was incubated in buffer containing AA-Me (1 pM-1 M) for 30 min and then rechallenged with ACh (1 M). Control experiments with ACh rechallenge after BEL were done without the AA-Me incubation. Additionally, to control for potential effects of the methyl ester moiety, experiments were also conducted in which the AA-Me was replaced with the methyl ester analogs of oleic and linoleic acids. To determine the endothelium dependence of the effects of AA-Me, it was also tested in vessels in which the endothelium had been removed by perfusion of the vessel lumen with air. Two controls were done to ensure that the endothelium denudation procedure did not damage the smooth muscle. First, we examined the response to PE before and after the procedure and, if there was more than a 10% decrease in the measured response after denudation (usually the vasoconstricting response to PE was slightly increased), the smooth muscle cells were considered damaged, and the vessel was not further studied. Second, endothelium-independent vasodilation in response to a fixed concentration of an NO donor (sodium nitroprusside) was measured before and after denudation. Again, if there was more than a 10% decrease in the vasodilatory response to NO (there was usually a slight increase in the response), the vessel was considered damaged and not studied further.
Role of AA Metabolites and NO. The effects of inhibitors of the cyclooxygenase (indomethacin; 10 M), the cytochrome P450 (17-ODYA; 10 M), the lipoxygenase (esculetin, 10 M), or the nitricoxide synthase (N -nitro-L-arginine, L-NNA; 100 M) pathways on responses to ACh and AA-Me were also studied. Inhibitors were added to the bath before and during application of ACh and/or AA-Me, and tested over a range of concentrations previously demonstrated to be effective in other systems.
Statistical Analysis. After verification that PE constrictions were not significantly different, the maximum relaxation was measured and normalized as the percentage of the PE constriction. Results are expressed as mean Ϯ S.E.M. The effects of the PLA 2 inhibitors were compared with the control responses using Student's t test with Bonferroni correction. A p value Ͻ0.01 was taken to indicate a significant difference. The nonparametric Mann-Whitney test was used for the other comparisons, with p Ͻ 0.05 taken to indicate a significant effect; n indicates the number of experiments, each obtained from a different rat.
Solutions and Drugs. Acetylcholine, phenylephrine, arachidonic acid, arachidonic acid methyl ester, linoleic acid methyl ester, oleic acid methyl ester, N -nitro-L-arginine, and indomethacin were purchased from Sigma-Aldrich (St. Louis, MO). 17-Octadecynoic acid, esculetin, BEL, and AACOCF 3 were purchased from BIOMOL Research Laboratories (Plymouth Meeting, PA).
Stock solutions of indomethacin, esculetin, arachidonic acid, arachidonic acid methyl ester, linoleic acid methyl ester, oleic acid methyl ester, 17-octadecynoic acid, BEL, and AACOCF 3 were dissolved in ethanol to a stock solution, then diluted in HEPES to give a final ethanol concentration Յ1% (v/v). Preliminary experiments indicated that 1% ethanol alone was without effect on our preparation. All other compounds were solubilized in H 2 O.
Results
Effect of PLA 2 Inhibitors. Pretreatment of the rat mesenteric arteries with BEL resulted in concentration-dependent inhibition of ACh relaxation in PE-constricted mesenteric arteries. The BEL-induced inhibition of ACh-mediated relaxation was enhanced when ACh was concomitantly administered with BEL (Fig. 1) . Pretreatment of the rat mesenteric arteries with 1 M BEL produced 53 Ϯ 13% inhibition when administered alone (Fig. 1, A and C) and 85 Ϯ 2% inhibition when applied with ACh (1 M) (Fig. 1, A and D) . AACOCF 3 , an inhibitor of both the iPLA 2 and cPLA 2 family enzymes, also inhibited ACh relaxation (by 71 Ϯ 12% at 1 M) (data not shown). Neither BEL nor AACOCF 3 had any AA Effects on ACh Relaxation after BEL. After ACh relaxation had nearly been abolished by BEL, preincubation with 1 pM to 1 M AA-Me resulted in near-complete recovery of the ACh relaxation (90 Ϯ 2, 84 Ϯ 3, and 86 Ϯ 7% relaxation, respectively) (Fig. 2) . The highest concentration of AA-Me tested (1 M) also had a significant relaxing effect by itself ( Fig. 2A) . Interestingly, after BEL treatment, the higher dose of AA-Me (1 M) also produced recovery of only a transient ACh relaxation (Fig. 2B) , in contrast to recovery of the complete and sustained ACh-induced relaxation with the lower dose (Fig. 2C) . As shown in Fig. 3A , the direct relaxing action of 1 M AA-Me was not significantly affected by BEL and was absent in endothelium-denuded vessels (Fig.  3, A and B) . Neither oleic acid nor linoleic acid methyl esters produced any significant relaxation (Fig. 3A) , indicating that the specificity of the relaxing action of AA-Me was due to the arachidonyl moiety.
Role of NO and AA Metabolites. The effect of inhibitors of the cyclooxygenase (indomethacin; 10 M), the cytochrome P450 (17-ODYA; 10 M), the lipoxygenase (esculetin; 10 M), or the nitric-oxide synthase (NOS) pathways (L-NNA; 100 M) on ACh and AA-Me responses are shown in Fig. 4 . As presented in the figure, the control ACh-mediated relaxation (Fig. 4A) , the AA-Me-recovered ACh relaxation after BEL treatment (Fig. 4B) , and the direct relaxing effect of AA-Me (Fig. 4C ) all had similar pharmacological responses to the inhibitors. The control ACh relaxation (Fig. 4A) , the BELinhibited ACh relaxation restored by AA-Me (Fig. 4B) , as well as the direct relaxing effect of AA-Me (Fig. 4C) , were each significantly inhibited by pretreatment with the NOS inhibitor, L-NNA. In contrast, no significant inhibition was produced by the three AA metabolic pathway inhibitors, even using prolonged incubations (up to 1 h) and higher concentrations than those previously reported to have effects in other systems. Interestingly, the cyclooxygenase pathway 
Discussion
Recent studies indicate that iPLA 2 is involved in stimulusevoked AA release in a variety of cell types Lehman et al., 1993; Wolf et al., 1997; Creer and McHowat, 1998; Akiba et al., 1999; Murakami et al., 1999) . In this study, we have shown that ACh relaxation was nearly abolished by the iPLA 2 -selective inhibitor BEL and that the ACh relaxation inhibited by BEL could be recovered by preincubation with a minute quantity of a cell-permeant analog of AA (AA-Me). In addition, BEL-mediated inhibition of AChinduced relaxation was potentiated by coapplication of BEL with ACh, as would be anticipated for a mechanism-based inhibitor, and is consistent with the notion that ACh activates iPLA 2 . Collectively, the results strongly suggest that iPLA 2 -derived AA is an important component of ACh-mediated endothelium-dependent relaxation in rat mesenteric resistance arteries.
The role of phospholipases in ACh-induced relaxation in mesenteric arteries has previously been demonstrated utilizing AACOCF 3 (Adeagbo and Henzel, 1998) . However, the lack of effect of BEL in this prior study suggested that cPLA 2 , not iPLA 2 , was involved. Although this finding appears to conflict with our results, the highest BEL concentration tested (0.3 M) in that earlier study is only effective in utilizing purified enzyme and is not effective in cellular systems. Indeed, submicromolar concentrations of BEL were ineffective at blocking ACh relaxation in the absence of cellular activation. Since AACOCF 3 inhibits the iPLA 2 and the cPLA 2 enzyme families (Lio et al., 1996) , our results using AACOCF 3 and BEL are both consistent with prior findings and strongly suggest the involvement of iPLA 2 in the generation of the AA required for ACh-induced endothelium-dependent relaxation in mesenteric vessels.
Remarkably, preincubation with a minute quantity (10 Ϫ12 M) of the cell-permeant methyl ester analog of the iPLA 2 product AA (AA-Me) resulted in near-complete recovery of the ACh relaxation nearly abolished by BEL. Indeed, this finding provides strong support for the concept that iPLA 2 -derived AA is involved in ACh relaxation. At the highest concentration tested, AA-Me also had a direct vascular-relaxing action in our model, and the relaxing action of AA-Me was both endothelium-dependent and AA-specific (i.e., it did not occur with oleic or linoleic acid methyl esters, and native AA had a similar effect). Fatty acids are transported across the plasma membrane by either spontaneous or enzymecatalyzed transmembrane flip flop followed by rapid thioesterification with CoA to form acyl-CoA. In initial experiments, we sought to "rescue" BEL-mediated inhibition of ACh-induced relaxation with nonesterified AA. However, reconstitution of ACh-induced relaxation after BEL treatment with nonesterified AA was inconsistent. In contrast, utilization of AA-Me (which avoids the trapping of AA as its thioester) produced consistent restoration of ACh-mediated relaxation, presumably through delivery of AA-Me to appropriate intracellular membrane compartments with subsequent hydrolysis to nonesterified AA. The data further indicate that AA metabolites of either the cytochrome P450 or lipoxygenase pathways do not appear to be important for ACh relaxation in this model, or for the ACh-recovering or the direct relaxing effects of AA-Me. Although these results may appear surprising given the recent evidence suggesting that cytochrome P450 monooxygenase metabolites of AA (notably epoxyeicosatrienoic acids) may act as an endotheliumdependent hyperpolarizing factor (Campbell et al., 1996) , other investigators have not been able to demonstrate the importance of cytochrome P450 metabolites (Vanheel and Van de Voorde, 1997) , and considerable evidence suggests the differing relative importance of NO and endotheliumdependent hyperpolarizing factor in specific arterial systems (Ding and Triggle, 2000) . Indomethacin potentiated both the ACh-recovering and -relaxing effect of AA-Me (1 M), suggesting that the presence of a high amount of AA can result jpet.aspetjournals.org in the production of constrictor prostanoids, as previously described (Adeagbo and Malik, 1991) .
Relaxation produced by ACh before BEL treatment, ACh relaxation recovered by AA-Me after BEL, as well as the direct relaxing effect of AA-Me, were all nearly completely abolished by preincubation with the NOS inhibitor, L-NNA. The findings that ACh and AA relaxations are blocked by NOS inhibitors are similar to those reported previously (Koller et al., 1993) . Thus, it seems likely that both ACh and AA produce relaxation that is dependent on activation of endothelial NOS (eNOS). In addition, both the relaxing effect of AA-Me and the AA-Me-recovered ACh relaxation were not affected by BEL but were blocked by the NOS inhibitor. Thus, BEL-mediated inhibition of ACh relaxation could not be due to a direct effect of BEL on NOS activity. Rather, the finding that preincubation with only picomolar concentrations of AA-Me (which had no direct relaxing effect) resulted in full recovery of the NOS-dependent ACh relaxation after BEL suggests that iPLA 2 -generated AA plays an essential permissive role in the series of biochemical events leading to eNOS activation after ACh stimulation.
ACh muscarinic receptors in endothelial cells are coupled via G proteins to the activation of phospholipase C, which results in the generation of inositol triphosphate and Ca 2ϩ release from intracellular stores. Previously, we have provided evidence to propose the calcium-depletion hypothesis of iPLA 2 activation. The essential elements of this hypothesis include the calcium-dependent association of calmodulin with iPLA 2 , leading to inhibition of iPLA 2 enzyme activity (Wolf and Gross, 1996) , and the activation of iPLA 2 by dissociation of iPLA 2 from calmodulin after internal store calcium depletion (Wolf et al., 1997) . The present results are consistent with the notion that ACh-mediated internal store calcium depletion results in de-inhibition of the calmodulin iPLA 2 complex, leading to the release of AA, thereby facilitating ACh-induced vascular relaxation.
Concomitant activation of intermediate conductance AChand Ca 2ϩ -activated K ϩ channels results in membrane hyperpolarization and Ca 2ϩ influx through nonselective membrane cation channels (Himmel et al., 1993; Nilius et al., 1997) . The increase in [Ca 2ϩ ] i is important for the activation of eNOS, a Ca 2ϩ -calmodulin-dependent enzyme (Presta et al., 1997) . Although the role of AA in this process is unclear, iPLA 2 -derived AA is capable of directly activating transfected Kv1.1 channels in Sf9 cells (Gubitosi-Klug et al., 1995) . Furthermore, some had proposed that Ca 2ϩ entry mechanisms other than depletion-activated channels may be important in agonist-evoked Ca 2ϩ influx (for review, see Elliott, 2001) . Finally, recent studies demonstrated that AA mediates activation of a novel noncapacitive Ca 2ϩ entry pathway following activation of transfected muscarinic receptors in human embryonic kidney 293 cells (Shuttleworth and Thompson, 1998; Mignen and Shuttleworth, 2000) . Although the effect of AA on ACh-induced [Ca 2ϩ ] i increases in endothelial cells is not known, these recent studies suggest that the potential importance of AA in ACh-mediated endothelium-dependent relaxation may be related to an essential role of AA in ACh-mediated increases in [Ca 2ϩ ] i . Such an effect may be mediated either by a direct effect of AA on K ϩ channels or by AA-induced activation of noncapacitive Ca 2ϩ entry.
